Skip Navigation
Skip to contents

J Pathol Transl Med : Journal of Pathology and Translational Medicine

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
8 "Tae-Jung Kim"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Case Study
Malignant Pleural Effusion from Metastatic Prostate Cancer: A Case Report with Unusual Cytologic Findings
Jinyoung Jeon, Tae-Jung Kim, Hong Sik Park, Kyo-Young Lee
J Pathol Transl Med. 2018;52(4):257-261.   Published online June 7, 2018
DOI: https://doi.org/10.4132/jptm.2018.05.08
  • 8,257 View
  • 115 Download
  • 2 Crossref
AbstractAbstract PDF
We present a case of 55-year-old man who complained of dyspnea and sputum for a month. He was an ex-smoker with a history of prostate cancer and pulmonary tuberculosis. Chest radiographs revealed bilateral pleural effusions of a small to moderate amount. Pigtail catheters were inserted for drainage. The pleural fluid consisted of large clusters and tightly cohesive groups of malignant cells, which however could not be ascribed to prostate cancer with certainty. We performed immunocytochemical panel studies to determine the origin of cancer metastasis. The immunostaining results were positive for prostate-specific antigen, alpha-methylacyl-coenzyme A racemase, and Nkx 3.1, consistent with prostate cancer. Pleural effusion associated with prostate cancer is rare. To our knowledge, this is the first case report in Korea to describe cytologic features of malignant pleural effusion associated with prostate cancer.

Citations

Citations to this article as recorded by  
  • Rare metastatic prostate cancer mimicking lymphoma with malignant pleural effusion
    Tung Liu, En Meng, Yu-Chun Lin, Tai-Kuang Chao, Yi-Ming Chang
    Journal of Medical Sciences.2022; 42(1): 46.     CrossRef
  • Bilateral pleural effusion: etiology, diagnostics
    N. A. Stogova
    PULMONOLOGIYA.2022; 32(6): 885.     CrossRef
Review
Molecular Testing of Lung Cancers
Hyo Sup Shim, Yoon-La Choi, Lucia Kim, Sunhee Chang, Wan-Seop Kim, Mee Sook Roh, Tae-Jung Kim, Seung Yeon Ha, Jin-Haeng Chung, Se Jin Jang, Geon Kook Lee
J Pathol Transl Med. 2017;51(3):242-254.   Published online April 21, 2017
DOI: https://doi.org/10.4132/jptm.2017.04.10
  • 13,832 View
  • 579 Download
  • 24 Web of Science
  • 22 Crossref
AbstractAbstract PDF
Targeted therapies guided by molecular diagnostics have become a standard treatment of lung cancer. Epidermal growth factor receptor (EGFR) mutations and anaplastic lymphoma kinase (ALK) rearrangements are currently used as the best predictive biomarkers for EGFR tyrosine kinase inhibitors and ALK inhibitors, respectively. Besides EGFR and ALK, the list of druggable genetic alterations has been growing, including ROS1 rearrangements, RET rearrangements, and MET alterations. In this situation, pathologists should carefully manage clinical samples for molecular testing and should do their best to quickly and accurately identify patients who will benefit from precision therapeutics. Here, we grouped molecular biomarkers of lung cancers into three categories—mutations, gene rearrangements, and amplifications—and propose expanded guidelines on molecular testing of lung cancers.

Citations

Citations to this article as recorded by  
  • miR-92a-3p regulates cisplatin-induced cancer cell death
    Romain Larrue, Sandy Fellah, Nihad Boukrout, Corentin De Sousa, Julie Lemaire, Carolane Leboeuf, Marine Goujon, Michael Perrais, Bernard Mari, Christelle Cauffiez, Nicolas Pottier, Cynthia Van der Hauwaert
    Cell Death & Disease.2023;[Epub]     CrossRef
  • Molecular Pathology of Lung Cancer
    James J. Saller, Theresa A. Boyle
    Cold Spring Harbor Perspectives in Medicine.2022; 12(3): a037812.     CrossRef
  • Landscape of EGFR mutations in lung adenocarcinoma: a single institute experience with comparison of PANAMutyper testing and targeted next-generation sequencing
    Jeonghyo Lee, Yeon Bi Han, Hyun Jung Kwon, Song Kook Lee, Hyojin Kim, Jin-Haeng Chung
    Journal of Pathology and Translational Medicine.2022; 56(5): 249.     CrossRef
  • Molecular biomarker testing for non–small cell lung cancer: consensus statement of the Korean Cardiopulmonary Pathology Study Group
    Sunhee Chang, Hyo Sup Shim, Tae Jung Kim, Yoon-La Choi, Wan Seop Kim, Dong Hoon Shin, Lucia Kim, Heae Surng Park, Geon Kook Lee, Chang Hun Lee
    Journal of Pathology and Translational Medicine.2021; 55(3): 181.     CrossRef
  • TM4SF4 and LRRK2 Are Potential Therapeutic Targets in Lung and Breast Cancers through Outlier Analysis
    Kyungsoo Jung, Joon-Seok Choi, Beom-Mo Koo, Yu Jin Kim, Ji-Young Song, Minjung Sung, Eun Sol Chang, Ka-Won Noh, Sungbin An, Mi-Sook Lee, Kyoung Song, Hannah Lee, Ryong Nam Kim, Young Kee Shin, Doo-Yi Oh, Yoon-La Choi
    Cancer Research and Treatment.2021; 53(1): 9.     CrossRef
  • The promises and challenges of early non‐small cell lung cancer detection: patient perceptions, low‐dose CT screening, bronchoscopy and biomarkers
    Lukas Kalinke, Ricky Thakrar, Sam M. Janes
    Molecular Oncology.2021; 15(10): 2544.     CrossRef
  • Cost-effectiveness analyses of targeted therapy and immunotherapy for advanced non-small cell lung cancer in the United States: a systematic review
    Anthony Yu, Eva Huang, Momoka Abe, Kang An, Sun-Kyeong Park, Chanhyun Park
    Expert Review of Pharmacoeconomics & Outcomes Research.2021; 21(3): 381.     CrossRef
  • The expanding capability and clinical relevance of molecular diagnostic technology to identify and evaluate EGFR mutations in advanced/metastatic NSCLC
    Parth Shah, Jacob Sands, Nicola Normanno
    Lung Cancer.2021; 160: 118.     CrossRef
  • Testing for EGFR Mutations and ALK Rearrangements in Advanced Non-Small-Cell Lung Cancer: Considerations for Countries in Emerging Markets
    Mercedes L Dalurzo, Alejandro Avilés-Salas, Fernando Augusto Soares, Yingyong Hou, Yuan Li, Anna Stroganova, Büge Öz, Arif Abdillah, Hui Wan, Yoon-La Choi
    OncoTargets and Therapy.2021; Volume 14: 4671.     CrossRef
  • Treatment of Patients With Non–Small-Cell Lung Cancer Harboring Rare Oncogenic Mutations
    Melina E. Marmarelis, Corey J. Langer
    Clinical Lung Cancer.2020; 21(5): 395.     CrossRef
  • Detection of Targetable Genetic Alterations in Korean Lung Cancer Patients: A Comparison Study of Single-Gene Assays and Targeted Next-Generation Sequencing
    Eunhyang Park, Hyo Sup Shim
    Cancer Research and Treatment.2020; 52(2): 543.     CrossRef
  • High prevalence of ROS1 gene rearrangement detected by FISH in EGFR and ALK negative lung adenocarcinoma
    Yuyin Xu, Heng Chang, Lijing Wu, Xin Zhang, Ling Zhang, Jing Zhang, Yuan Li, Lei Shen, Xiaoli Zhu, Xiaoyan Zhou, Qianming Bai
    Experimental and Molecular Pathology.2020; 117: 104548.     CrossRef
  • An All-In-One Transcriptome-Based Assay to Identify Therapy-Guiding Genomic Aberrations in Nonsmall Cell Lung Cancer Patients
    Jiacong Wei, Anna A. Rybczynska, Pei Meng, Martijn Terpstra, Ali Saber, Jantine Sietzema, Wim Timens, Ed Schuuring, T. Jeroen N. Hiltermann, Harry. J.M. Groen, Anthonie van der Wekken, Anke van den Berg, Klaas Kok
    Cancers.2020; 12(10): 2843.     CrossRef
  • Immunotherapy in EGFR-Mutant and ALK-Positive Lung Cancer
    Alexander Gavralidis, Justin F. Gainor
    The Cancer Journal.2020; 26(6): 517.     CrossRef
  • Role of Immunocytochemistry in the Cytological Diagnosis of Pulmonary Tumors
    Jasna Metovic, Luisella Righi, Luisa Delsedime, Marco Volante, Mauro Papotti
    Acta Cytologica.2020; 64(1-2): 16.     CrossRef
  • Molecular Diagnostic Assays and Clinicopathologic Implications of MET Exon 14 Skipping Mutation in Non–small-cell Lung Cancer
    Eun Kyung Kim, Kyung A. Kim, Chang Young Lee, Sangwoo Kim, Sunhee Chang, Byoung Chul Cho, Hyo Sup Shim
    Clinical Lung Cancer.2019; 20(1): e123.     CrossRef
  • PD‐L1 expression in ROS1‐rearranged non‐small cell lung cancer: A study using simultaneous genotypic screening of EGFR, ALK, and ROS1
    Jongmin Lee, Chan Kwon Park, Hyoung‐Kyu Yoon, Young Jo Sa, In Sook Woo, Hyo Rim Kim, Sue Youn Kim, Tae‐Jung Kim
    Thoracic Cancer.2019; 10(1): 103.     CrossRef
  • Human Leukocyte Antigen Class I and Programmed Death-Ligand 1 Coexpression Is an Independent Poor Prognostic Factor in Adenocarcinoma of the Lung
    Yeon Bi Han, Hyun Jung Kwon, Soo Young Park, Eun-Sun Kim, Hyojin Kim, Jin-Haeng Chung
    Journal of Pathology and Translational Medicine.2019; 53(2): 86.     CrossRef
  • Molecular testing for advanced non-small cell lung cancer in Malaysia: Consensus statement from the College of Pathologists, Academy of Medicine Malaysia, the Malaysian Thoracic Society, and the Malaysian Oncological Society
    Pathmanathan Rajadurai, Phaik Leng Cheah, Soon Hin How, Chong Kin Liam, Muhammad Azrif Ahmad Annuar, Norhayati Omar, Noriah Othman, Nurhayati Mohd Marzuki, Yong Kek Pang, Ros Suzanna Ahmad Bustamam, Lye Mun Tho
    Lung Cancer.2019; 136: 65.     CrossRef
  • Somatic mutations and immune checkpoint biomarkers
    Brielle A. Parris, Eloise Shaw, Brendan Pang, Richie Soong, Kwun Fong, Ross A. Soo
    Respirology.2019; 24(3): 215.     CrossRef
  • Adverse Event Management in Patients with BRAF V600E-Mutant Non-Small Cell Lung Cancer Treated with Dabrafenib plus Trametinib
    Anna Chalmers, Laura Cannon, Wallace Akerley
    The Oncologist.2019; 24(7): 963.     CrossRef
  • Genetic and clinicopathologic characteristics of lung adenocarcinoma with tumor spread through air spaces
    Jae Seok Lee, Eun Kyung Kim, Moonsik Kim, Hyo Sup Shim
    Lung Cancer.2018; 123: 121.     CrossRef
Brief Case Reports
Mucosal Schwann Cell Hamartoma in Colorectal Mucosa: A Rare Benign Lesion That Resembles Gastrointestinal Neuroma
Jiheun Han, Yosep Chong, Tae-Jung Kim, Eun Jung Lee, Chang Suk Kang
J Pathol Transl Med. 2017;51(2):187-189.   Published online August 25, 2016
DOI: https://doi.org/10.4132/jptm.2016.07.02
  • 9,676 View
  • 197 Download
  • 5 Web of Science
  • 11 Crossref
PDF

Citations

Citations to this article as recorded by  
  • Schwann Cell Hamartoma Presenting as a Colonic Polyp: A Rare Case Report With a Literature Review
    Faryal Altaf, Nismat Javed, Haider Ghazanfar, Anil Dev
    Cureus.2024;[Epub]     CrossRef
  • Multiple non-polypoid mucosal Schwann cell hamartomas presenting as edematous and submucosal tumor-like lesions: a case report
    Takeshi Okamoto, Takaaki Yoshimoto, Katsuyuki Fukuda
    BMC Gastroenterology.2021;[Epub]     CrossRef
  • Mucosal schwann cell hamartoma of the gall bladder
    Kanika Sharma, AnjanKumar Dhua, Prabudh Goel, Vishesh Jain, DevendraKumar Yadav, Prashant Ramteke
    Journal of Indian Association of Pediatric Surgeons.2021; 26(3): 182.     CrossRef
  • Mucosal Schwann Cell Hamartoma in sigmoid colon – A rare case report and review of literature
    Xiuyan Feng, Hongzhi Xu, Nestor Dela Cruz
    Human Pathology: Case Reports.2020; 19: 200337.     CrossRef
  • Spindle cell proliferations of the sigmoid colon, rectum and anus: a review with emphasis on perineurioma
    Patrice Grech, John B Schofield
    Histopathology.2020; 76(3): 342.     CrossRef
  • Mucosal Schwann cell hamartoma of the gastroesophageal junction: A series of 6 cases and comparison with colorectal counterpart
    Yuan Li, Pouneh Beizai, John W. Russell, Lindsey Westbrook, Arash Nowain, Hanlin L. Wang
    Annals of Diagnostic Pathology.2020; 47: 151531.     CrossRef
  • Mucosal Schwann Cell Hamartoma Presenting as Diffuse Fine Nodularities
    Han Beol Jang, Jong Ok Kim, Sang-Bum Kang
    The Korean Journal of Gastroenterology.2020; 76(3): 171.     CrossRef
  • A case of Schwann cell hamartoma of the tongue
    Saya TAKIKAWA, Shigeo TANAKA, Masamichi KOMIYA, Masaaki SUEMITSU, Tadahiko UTSUNOMIYA, Kayo KUYAMA
    Japanese Journal of Oral and Maxillofacial Surgery.2020; 66(12): 601.     CrossRef
  • Hamartoma de células de Schwann mucoso: revisión de una entidad descrita recientemente
    Francisco García-Molina, José Antonio Ruíz-Macia, Joaquin Sola
    Revista Española de Patología.2018; 51(1): 49.     CrossRef
  • Neural and neurogenic tumours of the gastroenteropancreaticobiliary tract
    Aoife J McCarthy, Dipti M Karamchandani, Runjan Chetty
    Journal of Clinical Pathology.2018; 71(7): 565.     CrossRef
  • Case of colonic mucosal Schwann cell hamartoma and review of literature on unusual colonic polyps
    JayaKrishna Chintanaboina, Kofi Clarke
    BMJ Case Reports.2018; : bcr-2018-224931.     CrossRef
Primary Neurilemmoma of the Thyroid Gland Clinically Mimicking Malignant Thyroid Nodule
Young Sub Lee, Jee Soon Kim, Arthur Minwoo Chung, Woo Chan Park, Tae-Jung Kim
J Pathol Transl Med. 2016;50(2):168-171.   Published online October 26, 2015
DOI: https://doi.org/10.4132/jptm.2015.08.26
  • 7,699 View
  • 67 Download
  • 3 Crossref
PDF

Citations

Citations to this article as recorded by  
  • A Case of Intra-thyroidal Schwannoma Diagnosed by Preoperative Core Needle Biopsy
    Dong Gyu Choi, Young-Ok Kim, Min Jung Jung, Hyoung Shin Lee
    Korean Society for Head and Neck Oncology.2023; 39(1): 37.     CrossRef
  • Multimodal ultrasound imaging of primary thyroid schwannoma
    Hai Na Zhao, Bu Yun Ma, Feng Yan, Yu Lan Peng
    Medicine.2021; 100(16): e25517.     CrossRef
  • A Case of Anterior Cervical Intramuscular Schwannoma in the Strap Muscle
    Seul Gi Lee, Ho-Ryun Won, Bon Seok Koo, Jae Won Chang
    Korean Journal of Otorhinolaryngology-Head and Neck Surgery.2021; 64(4): 263.     CrossRef
Necrotizing Sarcoid Granulomatosis: Possibly Veiled Disease in Endemic Area of Mycobacterial Infection
Yosep Chong, Eun Jung Lee, Chang Suk Kang, Tae-Jung Kim, Jung Sup Song, Hyosup Shim
J Pathol Transl Med. 2015;49(4):346-350.   Published online June 1, 2015
DOI: https://doi.org/10.4132/jptm.2015.04.17
  • 7,419 View
  • 74 Download
  • 11 Web of Science
  • 11 Crossref
PDF

Citations

Citations to this article as recorded by  
  • Sarcoidosis With Skeletal Involvement Masquerading as Metastatic Malignancy
    Arthur M Samia, Stephanie Fabara Pino, Liang Sun
    Cureus.2023;[Epub]     CrossRef
  • Necrotic sarcoid granulomatosis – a late stage of nodular sarcoidosis or an independent disease? Analysis of a clinical case
    E. A. Galushko, E. V. Pozhidaev, S. G. Radenska-Lopovok, A. V. Gordeev, M. V. Shaligina, A. V. Alekseeva, M. A. Sedelnikova
    Rheumatology Science and Practice.2023; 61(5): 624.     CrossRef
  • Incidental Lung Cavity in the Heartland
    Biplab K. Saha, Om Dawani, Woon H Chong, Alyssa Bonnier
    The American Journal of the Medical Sciences.2022; 363(2): 191.     CrossRef
  • A rare presentation of necrotizing sarcoidosis
    Nirali Sheth, Umaima Dhamrah, Branden Ireifej, David Song, Penpa Bhuti, Jagbir Singh, Henry Fan, Sibghatallah Ummar, Vikash Jaiswal, Nishan Babu Pokhrel
    Respirology Case Reports.2022;[Epub]     CrossRef
  • Necrotizing Granulomatous Dacryoadenitis With Non-Necrotizing Granulomatous Scar Hypertrophy: Two Histological Variants of Sarcoidosis in the Same Patient
    Erin E. Godbout, M. Kristina Subik, Tal J. Rubinstein
    Ophthalmic Plastic & Reconstructive Surgery.2021; 37(1): e30.     CrossRef
  • Necrotizing sarcoid granulomatosis simulating pulmonary malignancy
    Jun Hyeok Kim, Bo Da Nam, Jung Hwa Hwang, Dong Won Kim, Ki-Up Kim, Young Woo Park
    Medicine.2021; 100(49): e28208.     CrossRef
  • Necrotizing Sarcoid Granulomatosis: A Disease Not to be Forgotten
    A. I. Parejo-Morón, M. L. Tornero-Divieso, M. R. Férnandez-Díaz, L. Muñoz-Medina, O. Preda, N. Ortego-Centeno
    Case Reports in Medicine.2020; 2020: 1.     CrossRef
  • Clinical Reasoning: A woman with monocular vision loss
    Husain Danish, Tatiana Bakaeva, Isaac Solomon, Sashank Prasad
    Neurology.2020;[Epub]     CrossRef
  • Cavity forms of thoracic sarcoidosis (literature review, clinical and radiological observations)
    A. V. Lenshin, A. V. Il'in, Yu. M. Perelman
    PULMONOLOGIYA.2020; 30(6): 831.     CrossRef
  • Thoracic sarcoidosis versus tuberculosis: Need for a multi-disciplinary approach
    Agrima Mian, Animesh Ray
    Indian Journal of Radiology and Imaging.2018; 28(02): 267.     CrossRef
  • Necrotizing sarcoid granulomatosis with clinical presentations of recurrent acute abdomen. Case report and literature review
    V. I. Vasilyev, S. G. Palshina, B. D. Chaltsev, S. G. Radenska-Lopovok, T. N. Safonova
    Terapevticheskii arkhiv.2017; 89(11): 60.     CrossRef
Fine Needle Aspiration Cytology of Warthin-like Papillary Thyroid Carcinoma: A Brief Case Report
Yosep Chong, Sungwook Suh, Tae-Jung Kim, Eun Jung Lee
Korean J Pathol. 2014;48(2):170-173.   Published online April 28, 2014
DOI: https://doi.org/10.4132/KoreanJPathol.2014.48.2.170
  • 7,543 View
  • 38 Download
  • 10 Crossref
PDF

Citations

Citations to this article as recorded by  
  • Warthin-like variant of papillary thyroid carcinoma with lymph node metastases: a case report and review of the literature
    Andrii Hryshchyshyn, Andrii Bahrii, Pavlina Botsun, Volodymyr Chuba
    Journal of Medical Case Reports.2024;[Epub]     CrossRef
  • The Warthin-like variant of papillary thyroid carcinomas: a clinicopathologic analysis report of two cases
    Xing Zhao, Yijia Zhang, Pengyu Hao, Mingzhen Zhao, Xingbin Shen
    Oncologie.2023; 25(5): 581.     CrossRef
  • Solid papillary thyroid carcinoma with Hashimoto’s thyroiditis: description of a further case with challenging cytological features
    Franco Fulciniti, Jessica Barizzi, Pierpaolo Trimboli, Luca Giovanella
    BMJ Case Reports.2019; 12(1): e226153.     CrossRef
  • Preoperative Cytologic Diagnosis of Warthin-like Variant of Papillary Thyroid Carcinoma
    Jisup Kim, Beom Jin Lim, Soon Won Hong, Ju Yeon Pyo
    Journal of Pathology and Translational Medicine.2018; 52(2): 105.     CrossRef
  • Warthin like papillary carcinoma - A rare variant of papillary carcinoma thyroid
    Mir Wajahat, Tazeen Jeelani, Kanika Gupta, Nusrat Bashir
    Human Pathology: Case Reports.2018; 13: 21.     CrossRef
  • Cytological features of warthin‐like papillary thyroid carcinoma: A case report with review of previous cytology cases
    Archana George Vallonthaiel, Shipra Agarwal, Deepali Jain, Rajni Yadav, Nishikant A. Damle
    Diagnostic Cytopathology.2017; 45(9): 837.     CrossRef
  • Comparison of EASYPREP® and SurePath® in thyroid fine‐needle aspiration
    Yosep Chong, Ki Hyun Baek, Jee Young Kim, Tae‐Jung Kim, Eun Jung Lee, Chang Suk Kang
    Diagnostic Cytopathology.2016; 44(4): 283.     CrossRef
  • Ultrasonographic features and clinical characteristics of Warthin-like variant of papillary thyroid carcinoma
    Ga Ram Kim, Jung Hee Shin, Soo Yeon Hahn, Eun Young Ko, Young Lyun Oh
    Endocrine Journal.2016; 63(4): 329.     CrossRef
  • Warthin-Like Papillary Thyroid Carcinoma Associated with Lymphadenopathy and Hashimoto’s Thyroiditis
    Karla Judith González-Colunga, Abelardo Loya-Solis, Luis Ángel Ceceñas-Falcón, Oralia Barboza-Quintana, René Rodríguez-Gutiérrez
    Case Reports in Endocrinology.2015; 2015: 1.     CrossRef
  • Tumeur Warthin-like de la thyroïde : à propos d’un cas
    W. Rekik, A. Khadhar, A. Zehani, H. Azouz, I. Chelly, T. Ben Ghachem, A. Sellem, M. Tounsi, H. Ben Mahjouba, S. Haouet, N. Kchir
    Journal Africain du Cancer / African Journal of Cancer.2015; 7(4): 247.     CrossRef
Esophageal Squamous Cell Carcinoma In Situ Overlying Leiomyoma Mimicking Invasive Cancer: A Brief Case Report
Woo Jin Oh, Eun Jung Lee, Youn Soo Lee, Tae-Jung Kim
Korean J Pathol. 2014;48(2):162-163.   Published online April 28, 2014
DOI: https://doi.org/10.4132/KoreanJPathol.2014.48.2.162
  • 5,824 View
  • 36 Download
  • 2 Crossref
PDF

Citations

Citations to this article as recorded by  
  • Esophageal squamous cell carcinoma or high-grade dysplasia overlying leiomyoma, rare but not to be neglected
    Changyuan Guo, Dan Liu, Yong Liu, Lei Guo, Lulu Rong, Guiqi Wang, Ning Lu, Liyan Xue
    Esophagus.2021; 18(1): 125.     CrossRef
  • Esophageal leiomyoma and simultaneous overlying squamous cell carcinoma: a case report and review of the literature
    Saadat Mehrabi, Mohammad Javad Yavari Barhaghtalab, Safoora Hejazinia, Hossein Saedi
    BMC Surgery.2021;[Epub]     CrossRef
Review
Guideline Recommendations for Testing of ALK Gene Rearrangement in Lung Cancer: A Proposal of the Korean Cardiopulmonary Pathology Study Group
Hyojin Kim, Hyo Sup Shim, Lucia Kim, Tae-Jung Kim, Kun Young Kwon, Geon Kook Lee, Jin-Haeng Chung
Korean J Pathol. 2014;48(1):1-9.   Published online February 25, 2014
DOI: https://doi.org/10.4132/KoreanJPathol.2014.48.1.1
  • 12,321 View
  • 113 Download
  • 19 Crossref
AbstractAbstract PDF

Rearrangement of anaplastic lymphoma kinase (ALK) gene is the best predictor of response to crizotinib, an ALK tyrosine kinase inhibitor. However, the prevalence of the ALK fusion is low, so accurate patient identification is crucial for successful treatment using ALK inhibitors. Furthermore, most patients with lung cancer present with advanced-stage disease at the time of diagnosis, so it is important for pathologists to detect ALK-rearranged patients while effectively maximizing small biopsy or cytology specimens. In this review, we propose a guideline recommendation for ALK testing approved by the Cardiopulmonary Pathology Study Group of the Korean Society of Pathologists.

Citations

Citations to this article as recorded by  
  • Molecular Characteristics of Radon Associated Lung Cancer Highlights MET Alterations
    Gabriele Gamerith, Marcel Kloppenburg, Finn Mildner, Arno Amann, Sabine Merkelbach-Bruse, Carina Heydt, Janna Siemanowski, Reinhard Buettner, Michael Fiegl, Claudia Manzl, Georg Pall
    Cancers.2022; 14(20): 5113.     CrossRef
  • ALK Translocation in ALK-Positive Mesenchymal Tumors: Diagnostic and Therapeutic Insights
    Minsun Jung, Kyung Chul Moon, Jeongmo Bae, Tae Min Kim, Miso Kim, Yoon Kyung Jeon, Cheol Lee
    Archives of Pathology & Laboratory Medicine.2022; 146(12): 1460.     CrossRef
  • Molecular biomarker testing for non–small cell lung cancer: consensus statement of the Korean Cardiopulmonary Pathology Study Group
    Sunhee Chang, Hyo Sup Shim, Tae Jung Kim, Yoon-La Choi, Wan Seop Kim, Dong Hoon Shin, Lucia Kim, Heae Surng Park, Geon Kook Lee, Chang Hun Lee
    Journal of Pathology and Translational Medicine.2021; 55(3): 181.     CrossRef
  • Testing for EGFR Mutations and ALK Rearrangements in Advanced Non-Small-Cell Lung Cancer: Considerations for Countries in Emerging Markets
    Mercedes L Dalurzo, Alejandro Avilés-Salas, Fernando Augusto Soares, Yingyong Hou, Yuan Li, Anna Stroganova, Büge Öz, Arif Abdillah, Hui Wan, Yoon-La Choi
    OncoTargets and Therapy.2021; Volume 14: 4671.     CrossRef
  • Molecular testing for advanced non-small cell lung cancer in Malaysia: Consensus statement from the College of Pathologists, Academy of Medicine Malaysia, the Malaysian Thoracic Society, and the Malaysian Oncological Society
    Pathmanathan Rajadurai, Phaik Leng Cheah, Soon Hin How, Chong Kin Liam, Muhammad Azrif Ahmad Annuar, Norhayati Omar, Noriah Othman, Nurhayati Mohd Marzuki, Yong Kek Pang, Ros Suzanna Ahmad Bustamam, Lye Mun Tho
    Lung Cancer.2019; 136: 65.     CrossRef
  • Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors
    Neal I. Lindeman, Philip T. Cagle, Dara L. Aisner, Maria E. Arcila, Mary Beth Beasley, Eric H. Bernicker, Carol Colasacco, Sanja Dacic, Fred R. Hirsch, Keith Kerr, David J. Kwiatkowski, Marc Ladanyi, Jan A. Nowak, Lynette Sholl, Robyn Temple-Smolkin, Benj
    Journal of Thoracic Oncology.2018; 13(3): 323.     CrossRef
  • Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors
    Neal I. Lindeman, Philip T. Cagle, Dara L. Aisner, Maria E. Arcila, Mary Beth Beasley, Eric H. Bernicker, Carol Colasacco, Sanja Dacic, Fred R. Hirsch, Keith Kerr, David J. Kwiatkowski, Marc Ladanyi, Jan A. Nowak, Lynette Sholl, Robyn Temple-Smolkin, Benj
    The Journal of Molecular Diagnostics.2018; 20(2): 129.     CrossRef
  • Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the
    Neal I. Lindeman, Philip T. Cagle, Dara L. Aisner, Maria E. Arcila, Mary Beth Beasley, Eric H Bernicker, Carol Colasacco, Sanja Dacic, Fred R. Hirsch, Keith Kerr, David J. Kwiatkowski, Marc Ladanyi, Jan A. Nowak, Lynette Sholl, Robyn Temple-Smolkin, Benja
    Archives of Pathology & Laboratory Medicine.2018; 142(3): 321.     CrossRef
  • 5′/ 3′ imbalance strategy to detect ALK fusion genes in circulating tumor RNA from patients with non-small cell lung cancer
    Yongqing Tong, Zhijun Zhao, Bei Liu, Anyu Bao, Hongyun Zheng, Jian Gu, Mary McGrath, Ying Xia, Bihua Tan, Chunhua Song, Yan Li
    Journal of Experimental & Clinical Cancer Research.2018;[Epub]     CrossRef
  • Molecular testing and treatment patterns for patients with advanced non-small cell lung cancer: PIvOTAL observational study
    Dae Ho Lee, Ming-Sound Tsao, Karl-Otto Kambartel, Hiroshi Isobe, Ming-Shyan Huang, Carlos H. Barrios, Adnan Khattak, Filippo de Marinis, Smita Kothari, Ashwini Arunachalam, Xiting Cao, Thomas Burke, Amparo Valladares, Javier de Castro, Aamir Ahmad
    PLOS ONE.2018; 13(8): e0202865.     CrossRef
  • Microfluidics-based immunofluorescence for fast staining of ALK in lung adenocarcinoma
    Saška Brajkovic, Benjamin Pelz, Maria-Giuseppina Procopio, Anne-Laure Leblond, Grégoire Repond, Ariane Schaub-Clerigué, Diego G Dupouy, Alex Soltermann
    Diagnostic Pathology.2018;[Epub]     CrossRef
  • Expanded Circulating Tumor Cells from a Patient with ALK- Positive Lung Cancer Present with EML4-ALK Rearrangement Along with Resistance Mutation and Enable Drug Sensitivity Testing: A Case Study
    Zhuo Zhang, Hiroe Shiratsuchi, Nallasivam Palanisamy, Sunitha Nagrath, Nithya Ramnath
    Journal of Thoracic Oncology.2017; 12(2): 397.     CrossRef
  • Molecular Testing of Lung Cancers
    Hyo Sup Shim, Yoon-La Choi, Lucia Kim, Sunhee Chang, Wan-Seop Kim, Mee Sook Roh, Tae-Jung Kim, Seung Yeon Ha, Jin-Haeng Chung, Se Jin Jang, Geon Kook Lee
    Journal of Pathology and Translational Medicine.2017; 51(3): 242.     CrossRef
  • Novel ALK fusion partners in lung cancer
    Aglaya G. Iyevleva, Grigory A. Raskin, Vladislav I. Tiurin, Anna P. Sokolenko, Natalia V. Mitiushkina, Svetlana N. Aleksakhina, Aigul R. Garifullina, Tatiana N. Strelkova, Valery O. Merkulov, Alexandr O. Ivantsov, Ekatherina Sh. Kuligina, Kazimir M. Pozha
    Cancer Letters.2015; 362(1): 116.     CrossRef
  • Strategic management of transthoracic needle aspirates for histological subtyping and EGFR testing in patients with peripheral lung cancer: An institutional experience
    Choonhee Son, Eun‐Ju Kang, Mee Sook Roh
    Diagnostic Cytopathology.2015; 43(7): 532.     CrossRef
  • Current and future molecular diagnostics in non-small-cell lung cancer
    Chun Man Li, Wing Ying Chu, Di Lun Wong, Hin Fung Tsang, Nancy Bo Yin Tsui, Charles Ming Lok Chan, Vivian Wei Wen Xue, Parco Ming Fai Siu, Benjamin Yat Ming Yung, Lawrence Wing Chi Chan, Sze Chuen Cesar Wong
    Expert Review of Molecular Diagnostics.2015; 15(8): 1061.     CrossRef
  • Role of biopsy sampling for diagnosis of early and progressed hepatocellular carcinoma
    Haeryoung Kim, Young Nyun Park
    Best Practice & Research Clinical Gastroenterology.2014; 28(5): 813.     CrossRef
  • Molecular Pathology of Lung Cancer: Current Status and Future Directions
    Mee Sook Roh
    Tuberculosis and Respiratory Diseases.2014; 77(2): 49.     CrossRef
  • Epidermal growth factor receptor mutations and anaplastic lymphoma kinase rearrangements in lung cancer with nodular ground-glass opacity
    Sung-Jun Ko, Yeon Joo Lee, Jong Sun Park, Young-Jae Cho, Ho Il Yoon, Jin-Haeng Chung, Tae Jung Kim, Kyung Won Lee, Kwhanmien Kim, Sanghoon Jheon, Hyojin Kim, Jae Ho Lee, Choon-Taek Lee
    BMC Cancer.2014;[Epub]     CrossRef

J Pathol Transl Med : Journal of Pathology and Translational Medicine